Stay updated on Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial
Sign up to get notified when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.

Latest updates to the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study history now shows a new revision entry (v3.6.5) added to the record and the previous revision (v3.6.4) removed, updating the historical log to reflect the latest revision.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry (v3.6.4) is added to the study record history. The previous revision (v3.6.3) is removed, signaling an update to the record.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the study's history. The prior revision entry v3.6.2 was removed from the current change set.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history page now displays a revision tag of v3.6.2, replacing the previous v3.6.0. This indicates a platform-side update to the page rendering without changes to the underlying study data.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history now shows that the study is no longer recruiting participants, indicating recruitment has ceased. The revision tag was updated to v3.6.0, replacing the previous v3.5.5 entry in the version history.SummaryDifference0.3%

- Check74 days agoChange DetectedA new site revision label v3.5.5 is added to the record history, replacing the former v3.5.4 label and updating the documented version of the ClinicalTrials.gov interface.SummaryDifference0.1%

Stay in the know with updates to Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.